On November 6, 2019, the bonds between the U.S. government and pharmaceutical companies were stretched when the U.S. Department of Health and Human Services (“HHS”) filed a patent infringement lawsuit against Gilead Sciences...more
12/10/2019
/ Corporate Counsel ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Gilead Sciences ,
HIV ,
Manufacturers ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Prescription Drugs ,
Trump Administration
The August 13, 2019 decision from the United States District Court for the District of New Jersey in WAG Acquisition, LLC v. Multi Media LLC, Civil Action No. 2-14-cv-02340, deals a blow to a common attack on litigation...more
On January 27, 2016, the International Trade Commission (ITC) formally requested a rehearing en banc of a November 10, 2015, Federal Circuit panel decision in ClearCorrect Operating, LLC v. ITC. The Federal Circuit’s panel...more
On November 10, 2015, the Federal Circuit issued its opinion in ClearCorrect Operating, LLC v. ITC, and struck a blow to both the ITC and the entertainment and software industries by overturning the ITC’s opinion and finding...more
The International Trade Commission proposed a series of new procedural rules, which were published in the Federal Register on September 24, 2015. This blog post provides a summary of the more notable proposed changes to the...more
9/29/2015
/ Abusive Discovery Strategies ,
Comment Period ,
Corporate Counsel ,
Evidentiary Hearings ,
Expert Witness ,
Federal Register ,
Federal Rules of Civil Procedure ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Motion for Sanctions ,
NPRM ,
Patents ,
Popular ,
Privileged Communication ,
Proposed Regulation ,
Rules of Practice ,
Severability Doctrine ,
Young Lawyers